GB0705023D0 - Controlled release system - Google Patents

Controlled release system

Info

Publication number
GB0705023D0
GB0705023D0 GBGB0705023.0A GB0705023A GB0705023D0 GB 0705023 D0 GB0705023 D0 GB 0705023D0 GB 0705023 A GB0705023 A GB 0705023A GB 0705023 D0 GB0705023 D0 GB 0705023D0
Authority
GB
United Kingdom
Prior art keywords
controlled release
release system
controlled
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0705023.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nottingham Trent University
Original Assignee
Nottingham Trent University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nottingham Trent University filed Critical Nottingham Trent University
Priority to GBGB0705023.0A priority Critical patent/GB0705023D0/en
Publication of GB0705023D0 publication Critical patent/GB0705023D0/en
Priority to EP08718733A priority patent/EP2136845A2/en
Priority to PCT/GB2008/000891 priority patent/WO2008110813A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/559—Redox delivery systems, e.g. dihydropyridine pyridinium salt redox systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6957—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/202—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a naphthalene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB0705023.0A 2007-03-15 2007-03-15 Controlled release system Ceased GB0705023D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0705023.0A GB0705023D0 (en) 2007-03-15 2007-03-15 Controlled release system
EP08718733A EP2136845A2 (en) 2007-03-15 2008-03-14 Controlled release system
PCT/GB2008/000891 WO2008110813A2 (en) 2007-03-15 2008-03-14 Controlled release system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0705023.0A GB0705023D0 (en) 2007-03-15 2007-03-15 Controlled release system

Publications (1)

Publication Number Publication Date
GB0705023D0 true GB0705023D0 (en) 2007-04-25

Family

ID=38008507

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0705023.0A Ceased GB0705023D0 (en) 2007-03-15 2007-03-15 Controlled release system

Country Status (3)

Country Link
EP (1) EP2136845A2 (en)
GB (1) GB0705023D0 (en)
WO (1) WO2008110813A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114163448A (en) * 2021-11-11 2022-03-11 北京大学深圳研究生院 Host material based on naphtho five-membered heterocycle and benzo five-membered heterocycle, preparation method thereof and organic light-emitting device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035346A1 (en) * 2000-08-14 2002-03-21 Reynolds John R. Drug release (delivery system)
EP1812480A4 (en) * 2004-10-14 2010-11-03 Tufts College Electrochemically degradable polymers

Also Published As

Publication number Publication date
WO2008110813A3 (en) 2009-04-30
EP2136845A2 (en) 2009-12-30
WO2008110813A2 (en) 2008-09-18

Similar Documents

Publication Publication Date Title
EP2196131A4 (en) Introduction-into-subject system
EP2160695A4 (en) Activation system architecture
EP3542792C0 (en) Controlled release 25-hydroxyvitamin d
EP2160129A4 (en) Rotate-to-advance catheterizaton system
PL2185293T3 (en) Application system
EP2069956A4 (en) Tv-centric system
PL389467A1 (en) Structural system
EP2194893A4 (en) Implant system
GB2467497B (en) Adaptable launching system
GB2450342B (en) Control System
GB0709061D0 (en) Expression system
DK200901203A (en) Hydroponisk system
ZA201002402B (en) Control system
TWI340253B (en) Positioning system
HK1124421A1 (en) Position specifying system
GB0723290D0 (en) Braking system
HK1147354A1 (en) Two-power-source system
EP2074825A4 (en) Tv-centric system
GB0704931D0 (en) Rotocraft system
GB2453562B (en) Braking system
GB0713955D0 (en) Safety system
GB0701205D0 (en) Safety system
GB0705023D0 (en) Controlled release system
GB2455886B (en) Control system
GB0715531D0 (en) Vibracook system

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)